Sharon Mates, Chairman, President & CEO: Intra-Cellular Therapies ITCI Sell · Filed 23/03/13

Trade details

Type: Insider sale
Amount: $1,513,285.2
Shares · price: 34,965 sh · $43.28 a share
Held after: 1,137,114 sh
Stock: Intra-Cellular Therapies ITCI
Person: Sharon MatesChairman, President & CEO
Trade date: 23/03/10
Filed: 23/03/13
Days to filing: 3 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/02/08~23/04/09

Sharon Mates's recent trades

Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$4.2M
50,163 sh
$4.2M
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.4M
27,667 sh
$2.4M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2M
23,333 sh
$2M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$129.9K
1,534 sh
$129.9K
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.2M
29,832 sh
$2.2M
Filed 24/08/30
Traded 24/08/29

Sharon Mates, Chairman — sold $1.5M of Intra-Cellular Therapies ITCI · 3.0% of holdings | Whalegun